LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about ReNAgade Therapeutics…

ReNAgade Therapeutics Tech Stack

ReNAgade Therapeutics uses 8 technology products and services including Amazon Web Services, Microsoft 365, RequireJS, and more. Explore ReNAgade Therapeutics's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Microsoft 365
    Email
  • RequireJS
    Javascript Frameworks
  • Angular
    Javascript Frameworks
  • Glide.js
    Javascript Libraries
  • Netlify
    Platform As A Service
  • X-XSS-Protection
    Security
  • HSTS
    Security

Media & News

ReNAgade Therapeutics's Email Address Formats

ReNAgade Therapeutics uses at least 1 format(s):
ReNAgade Therapeutics Email FormatsExamplePercentage
FLast@renagadetx.comJDoe@renagadetx.com
50%
FLast@renagadetx.comJDoe@renagadetx.com
50%

Frequently Asked Questions

Where is ReNAgade Therapeutics's headquarters located?

Minus sign iconPlus sign iconReNAgade Therapeutics's main headquarters is located at 1 Broadway 11th Floor Cambridge, Massachusetts 02142 United States. The company has employees across 1 continents, including North America.

What is ReNAgade Therapeutics's official website and social media links?

Minus sign iconPlus sign iconReNAgade Therapeutics's official website is renagadetx.com and has social profiles on LinkedInCrunchbase.

What is ReNAgade Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconReNAgade Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ReNAgade Therapeutics have currently?

Minus sign iconPlus sign iconAs of March 2026, ReNAgade Therapeutics has approximately 24 employees across 1 continents, including North America. Key team members include Chief Executive Officer & President: A. M.Chief People Officer: L. V.Senior Research Associate: K. G.. Explore ReNAgade Therapeutics's employee directory with LeadIQ.

What industry does ReNAgade Therapeutics belong to?

Minus sign iconPlus sign iconReNAgade Therapeutics operates in the Biotechnology Research industry.

What technology does ReNAgade Therapeutics use?

Minus sign iconPlus sign iconReNAgade Therapeutics's tech stack includes Amazon Web ServicesMicrosoft 365RequireJSAngularGlide.jsNetlifyX-XSS-ProtectionHSTS.

What is ReNAgade Therapeutics's email format?

Minus sign iconPlus sign iconReNAgade Therapeutics's email format typically follows the pattern of FLast@renagadetx.com. Find more ReNAgade Therapeutics email formats with LeadIQ.

How much funding has ReNAgade Therapeutics raised to date?

Minus sign iconPlus sign icon As of March 2026, ReNAgade Therapeutics has raised $300M in funding. The last funding round occurred on May 23, 2023 for $300M.

When was ReNAgade Therapeutics founded?

Minus sign iconPlus sign iconReNAgade Therapeutics was founded in 2021.

ReNAgade Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing and gene insertion to develop new medicines.

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines. 

ReNAgade Therapeutics – RNA Without Limits

Section iconCompany Overview

Headquarters
1 Broadway 11th Floor Cambridge, Massachusetts 02142 United States
Website
renagadetx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $300M

    ReNAgade Therapeutics has raised a total of $300M of funding over 1 rounds. Their latest funding round was raised on May 23, 2023 in the amount of $300M.

  • $1M$10M

    ReNAgade Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $300M

    ReNAgade Therapeutics has raised a total of $300M of funding over 1 rounds. Their latest funding round was raised on May 23, 2023 in the amount of $300M.

  • $1M$10M

    ReNAgade Therapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    A. M.
    Chief Executive Officer & President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. V.
    Chief People Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. G.
    Senior Research Associate
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. D.
    Principal Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. T. G.
    Principal Research Associate, Delivery Chemistry
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    L. J.
    Truck Driver
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. V.
    Drug Discovery And Bioanalysis Co-Op
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.